Improving Diversity and Inclusion in Clinical Trials


Back to Package

  • Describe the importance of including diverse populations in clinical trials
  • Identify strategies to improve diversity, inclusion, and equity in clinical trials
  • List barriers or perceptions that prevent or limit diversity, inclusion, and equity in clinical trials

F. Diane Barber

PhD, ANP-BC, AOCNP, FAANP, FAAN

Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program) University of Texas MD Anderson Cancer Center

F. Diane Barber has no relevant financial disclosures

Key:

Complete
Failed
Available
Locked
Pre-Test: Improving Diversity and Inclusion in Clinical Trials
3 Questions  |  1 attempt  |  0/3 points to pass  |  Graded as Pass/Fail
3 Questions  |  1 attempt  |  0/3 points to pass  |  Graded as Pass/Fail This pre-test is designed to assess your current knowledge on this topic. Please answer the questions to the best of your ability. There is no time limit and your response will be kept confidential. This is required to move on to the next component.
You must register to access.
Improving Diversity and Inclusion in Clinical Trials
Open to view video.
Open to view video.
You must register to access.
Post-Test: Improving Diversity and Inclusion in Clinical Trials
3 Questions  |  3 attempts  |  3/3 points to pass
3 Questions  |  3 attempts  |  3/3 points to pass This post-test is required to earn your CE certificate. You must answer all the questions correctly to earn credit for this module. You have 3 attempts to pass the post-test.
You must register to access.
Evaluation: Improving Diversity and Inclusion in Clinical Trials
17 Questions
17 Questions Please review and answer all the required questions.
You must register to access.
CE Certificates: Improving Diversity and Inclusion in Clinical Trials
Up to 0.50 CE credits available  |  Certificate available
Up to 0.50 CE credits available  |  Certificate available
You must register to access.